Tenaya Therapeutics, Inc. (TNYA)

NASDAQ: TNYA · Real-Time Price · USD

0.7830

-0.0743 (-8.67%)

At close: May 18, 2026, 4:00 PM EDT

0.7949

+0.0119 (1.52%)

After-hours: May 18, 2026, 5:19 PM EDT

Tenaya Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	0.23	-	-	-	-	-
Gross Profit	0.23	-	-	-	-	-
Selling, General & Admin	23.71	24.72	29.21	33.16	31.08	18.41
Research & Development	62.37	68.61	86.74	98.04	94.54	54.39
Total Operating Expenses	86.08	93.33	115.95	131.19	125.62	72.81
Operating Income	-85.86	-93.33	-115.95	-131.19	-125.62	-72.81
Interest Income	2.84	2.68	4.74	7.06	1.95	0.11
Other Non-Operating Income (Expense)	0.01	0.05	0.08	0.05	0	-0.02
Total Non-Operating Income (Expense)	2.85	2.73	4.82	7.11	1.96	0.09
Pretax Income	-83.01	-90.6	-111.13	-124.08	-123.67	-72.72
Net Income	-83.01	-90.6	-111.13	-124.08	-123.67	-72.72
Net Income to Common	-83.01	-90.6	-111.13	-124.08	-123.67	-72.72
Shares Outstanding (Basic)	180	153	85	74	45	18
Shares Outstanding (Diluted)	180	153	85	74	45	18
Shares Change (YoY)	95.18%	80.34%	14.96%	64.61%	152.75%	1724.34%
EPS (Basic)	-0.47	-0.59	-1.31	-1.68	-2.76	-4.10
EPS (Diluted)	-0.47	-0.59	-1.31	-1.68	-2.76	-4.10
Shares Outstanding	217	216.76	86.54	68.33	66.86	41.29
Free Cash Flow	-64.63	-68.88	-91.53	-103.31	-125.05	-85.93
Free Cash Flow Per Share	-0.36	-0.45	-1.08	-1.40	-2.79	-4.85
Gross Margin	100.00%	-	-	-	-	-
Operating Margin	-38159.10%	-	-	-	-	-
Profit Margin	-36891.10%	-	-	-	-	-
FCF Margin	-28725.30%	-	-	-	-	-
EBITDA	-78.32	-84.9	-107.48	-122.51	-119.15	-69.85
EBITDA Margin	-34808.90%	-	-	-	-	-
EBIT	-85.86	-93.33	-115.95	-131.19	-125.62	-72.81
EBIT Margin	-38159.10%	-	-	-	-	-

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q